Loading data
MAZENasdaq
| Unit: USD | FY2025 | FY2024 |
|---|---|---|
| Revenue | — | 167.5 m USD |
| Research and development expense | 108.45 m USD | 83.5 m USD |
| Operating profit | -142.9 m USD | 57.59 m USD |
| Profit before tax | -131.12 m USD | 53.4 m USD |
| Income tax expense | 0 USD | 1.2 m USD |
| Net income (reported basis) | -131.12 m USD | 52.23 m USD |
| Net income attributable to common shareholders | -131.12 m USD | 3.41 m USD |
| Basic earnings per share | -3.05 USD/share | 1.42 USD/share |
| Diluted earnings per share | -3.05 USD/share | 1.25 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.